AQR Capital Management LLC Purchases 4,365 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

AQR Capital Management LLC boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 14.9% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 33,592 shares of the medical equipment provider's stock after buying an additional 4,365 shares during the period. AQR Capital Management LLC's holdings in Intuitive Surgical were worth $17,534,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Atala Financial Inc acquired a new stake in Intuitive Surgical during the 4th quarter worth about $25,000. Berbice Capital Management LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at about $26,000. BankPlus Trust Department purchased a new position in shares of Intuitive Surgical during the 4th quarter valued at $28,000. Hurley Capital LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter valued at about $28,000. Finally, Summit Securities Group LLC bought a new position in shares of Intuitive Surgical during the 4th quarter valued at $30,000. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Price Performance

NASDAQ ISRG traded up $2.64 during mid-day trading on Thursday, reaching $538.79. 1,469,311 shares of the stock were exchanged, compared to its average volume of 1,628,393. The stock has a market cap of $193.11 billion, a P/E ratio of 84.05, a P/E/G ratio of 5.85 and a beta of 1.70. The stock has a 50 day simple moving average of $501.93 and a 200-day simple moving average of $534.44. Intuitive Surgical, Inc. has a one year low of $379.67 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.10. The firm had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same period in the previous year, the firm earned $1.50 earnings per share. Sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Ratings Changes

Several brokerages have commented on ISRG. Piper Sandler lowered their price target on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a report on Wednesday, April 23rd. Erste Group Bank downgraded shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Monday, March 17th. Leerink Partners boosted their target price on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Truist Financial cut their price objective on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a research report on Wednesday, April 23rd. Finally, JPMorgan Chase & Co. upped their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an "overweight" rating in a research report on Friday, January 24th. Five investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $598.95.

Insider Activity at Intuitive Surgical

In other news, CFO Jamie Samath sold 269 shares of the company's stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $590.00, for a total transaction of $158,710.00. Following the transaction, the chief financial officer now directly owns 3,282 shares of the company's stock, valued at $1,936,380. This represents a 7.58 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Myriam Curet sold 408 shares of Intuitive Surgical stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total transaction of $240,618.00. Following the completion of the sale, the executive vice president now directly owns 353 shares of the company's stock, valued at approximately $208,181.75. The trade was a 53.61 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 33,313 shares of company stock valued at $17,229,143 in the last three months. Corporate insiders own 0.70% of the company's stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.